- Methylene blue has been shown to shrink tumors and slow cancer growth by targeting cancer cell metabolism and energy production
- Photodynamic therapy with methylene blue uses light activation to destroy cancer cells while leaving healthy cells unharmed, making it a more precise treatment option
- Research on ovarian cancer found that methylene blue forces tumors to shift away from their preferred energy source, making them more vulnerable to treatment
- Unlike chemotherapy, methylene blue treatment does not cause significant side effects or toxicity, making it a promising option for patients with drug-resistant cancers
- Proper dosing is important. Just 5 milligrams of pharmaceutical-grade methylene blue per day is enough to reduce cellular stress and support mitochondrial health
Conventional cancer treatments often come with debilitating side effects. For example, chemotherapy and radiation therapy not only target tumors but also damage healthy cells, leaving patients weakened and vulnerable to infections. In an effort to find safer treatment options for patients, researchers are now testing the efficacy of methylene blue — a commonly used dye that enhances cellular energy production — in treating cancer.
Methylene Blue Photodynamic Therapy Shrinks Tumors
A systematic review published in Frontiers in Pharmacology analyzed the effects of methylene blue in photodynamic therapy for cancer treatment. Researchers reviewed 10 preclinical studies from different countries assessing how methylene blue, when activated by light, impacts tumor growth.
- Methylene blue targets different cancers — The analysis covered different types of cancer, including colorectal tumors, melanoma and carcinoma, highlighting methylene blue’s ability to shrink tumors through a highly targeted mechanism that spares healthy tissue. A total of 133 mice were used, with 59 receiving methylene blue photodynamic therapy and 74 serving as untreated controls.1
- Antitumor properties of methylene blue — The researchers found that methylene blue significantly reduced tumor sizes in seven of the 10 studies, with reductions ranging from 12% to complete tumor elimination.
The largest effects were seen in colorectal cancer models, where tumors shrank by up to 99.9%, while some breast cancer models showed slower tumor progression rather than outright shrinkage. These results show methylene blue has strong anticancer effects, though its impact varies depending on tumor type and drug delivery method.2
- The use of light to fight cancer — Photodynamic therapy relies on methylene blue’s ability to absorb light in the 630 to 680 nanometer wavelength range. When exposed to this specific type of light, methylene blue generates reactive oxygen species (ROS), highly reactive molecules that destroy cancer cells from within.
This process selectively targets tumor cells because methylene blue accumulates in malignant tissue while sparing healthy cells. The review found that this light-activated destruction was particularly effective in skin and colorectal tumors, leading to significant tumor reduction within weeks of treatment.3
New Technology Improves Bioavailability of Methylene Blue
One of the most promising findings involved the use of nanotechnology to enhance methylene blue’s anticancer effects. Five studies included in the review used nanoformulations — tiny carriers designed to improve the drug’s stability and absorption.4
- Increased bioavailability — According to the researchers, the nano-based versions of methylene blue led to even greater tumor reduction than traditional injections. For instance, a breast cancer study using methylene blue-loaded nanoparticles resulted in complete tumor eradication.5
- Experiments in dosages — Tumor response also depended on the number of methylene blue treatments administered. While some studies used a single injection, others administered up to seven doses over time. More frequent treatments generally resulted in greater tumor shrinkage. For example, one carcinoma model that received seven doses showed significantly slower tumor growth compared to models that received only one or two doses.6
- Results are positive, but sometimes inconsistent — While methylene blue photodynamic therapy was effective in most studies, the review noted some inconsistencies. In a few cases, tumors did not shrink but instead grew more slowly than untreated tumors. This was observed in some breast cancer models, where tumor reduction was not as dramatic as in other cancers.
Researchers theorize that this variation is due to differences in how well methylene blue is absorbed in different tissue types. Some cancers may require modifications in dosing, delivery methods or additional combination therapies to enhance treatment effects.7
- Improved antitumor response — Beyond its ability to destroy cancer cells, methylene blue also helps enhance the immune system’s response to tumors. The meta-analysis shows that ROS generated during photodynamic therapy triggers immune activation, helping the body recognize and attack remaining cancer cells.
This immune-boosting effect likely explains why some tumors continued to shrink even after photodynamic therapy sessions ended. However, more research is needed to confirm this mechanism to help improve long-term treatment outcomes.8
- Safe to use — Methylene blue’s safety profile is another advantage noted in the review. Unlike chemotherapy and radiation, which cause widespread damage to healthy cells, photodynamic therapy with methylene blue resulted in minimal side effects in animal models.
The treatment selectively targeted cancerous tissue without causing significant harm to surrounding healthy cells, making it a promising option for patients who cannot tolerate conventional treatments. Additionally, methylene blue is relatively inexpensive, meaning it offers a more affordable alternative to expensive targeted cancer therapies.9
These findings reinforce methylene blue’s growing reputation as a powerful tool in cancer treatment. By leveraging light-activated therapy, this compound offers a way to precisely target tumors while minimizing damage to healthy cells.10
Methylene Blue Disrupts Cancer Cell Metabolism
In an animal study published in Cancers, a team of Canadian researchers explored how methylene blue affects ovarian cancer growth at the metabolic level. The findings revealed that methylene blue significantly slowed tumor growth, and more importantly, targets cancer cell metabolism, altering how tumors generate energy and making them more vulnerable to destruction.11
- Methylene blue works as a chemotherapy adjunct — The researchers used an ovarian cancer model where human tumor cells were implanted into immunodeficient mice. These particular cells were resistant to carboplatin, a chemotherapy drug commonly used to treat ovarian cancer. This resistance is a major problem in real-world treatment, as many patients eventually stop responding to standard chemotherapy.
The study compared multiple treatment groups — mice receiving methylene blue alone, methylene blue combined with carboplatin, carboplatin alone and an untreated control group. Tumors in the methylene blue group grew significantly slower than those in the control and carboplatin-only groups, demonstrating its effectiveness even against drug-resistant cancer.12
- Cancer cell energy production is affected — Cancer cells thrive on a dysfunctional metabolism known as the Warburg effect, which prioritizes glucose fermentation over normal oxygen-based energy production. This metabolic switch allows tumors to grow rapidly and resist many treatments.
With this in mind, the study found that methylene blue disrupted this process, forcing cancer cells to rely on oxygen-based energy production again. This shift puts immense stress on the tumor cells, making it harder for them to survive and multiply.13
- Mitochondrial genes are targeted — Cancer cells treated with methylene blue had lower expression of key respiratory chain genes, particularly those involved in complex IV, which is responsible for oxygen reduction.
In other words, methylene blue interfered with the tumor’s ability to efficiently process oxygen, further disrupting its energy supply. This effect was much more pronounced in cancer cells than in normal cells, reinforcing methylene blue’s selective action against tumors.14
- Virtually nontoxic — Methylene blue did not cause noticeable toxicity in the test mice. Unlike chemotherapy, which often leads to severe side effects like weight loss and immune suppression, mice receiving methylene blue maintained stable body weight and showed no signs of distress.
This is a critical advantage, as one of the biggest challenges in cancer treatment is balancing effectiveness with patient quality of life. The ability to target tumors without causing widespread damage makes methylene blue an attractive option for future therapies.15
These findings provide strong evidence that methylene blue is not just a photodynamic agent but also a metabolic disruptor in cancer therapy. By forcing tumors to shift away from their preferred energy source, methylene blue makes them more vulnerable to treatment.16
Safety and Dosage Recommendations for Methylene Blue
Based on these findings, it’s easy to fall into the idea that “more is better” when it comes to taking methylene blue for your health. However, don’t fall into this trap. As mentioned in my interview with metabolic health expert Georgi Dinkov, getting the proper dose is important to avoid severe adverse effects. One example is serotonin syndrome — a fatal condition caused by excessive serotonin levels in the brain.
- Contraindications of methylene blue — It is a potent monoamine oxidase type A (MAO-A) inhibitor. This means that when it is combined with a selective serotonin reuptake inhibitor (SSRI) or other serotonergic drugs, your serotonin levels can increase to dangerous levels.
Methylene blue can interact with other medications, too, including other antidepressants and antimalarials, altering their efficacy or causing adverse reactions. In addition, methylene blue is contraindicated for people diagnosed with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of hemolytic anemia (a blood disorder wherein your red blood cells break down faster than your body can replace them).
- Your urine will turn blue — Be aware that methylene blue can stain your urine and occasionally, your tongue. While these effects are harmless, it will most likely surprise you when it happens.
- False pulse oximeter readings — High doses can also interfere with pulse oximeter readings, due to its light absorption properties, resulting in falsely low oxygen saturation readings.
- A note for those with kidney damage — If you have severe renal insufficiency, it would be wise to use methylene blue with caution and under close medical supervision as impaired kidney function influences how fast drugs clear from your system.
- Other side effects of methylene blue — Examples include mild and transient gastrointestinal discomfort, such as nausea and diarrhea. While rare, a wide range of allergic reactions, from skin rashes to life-threatening anaphylaxis, can also occur. Headaches and confusion have also been reported. Though less common, cardiovascular effects, such as increased blood pressure and palpitations, could also occur.
- Low doses are better — Methylene blue is better taken at small, daily doses, ranging from 5 to 15 milligrams (mg), according to Dinkov, especially for long-term use. This is the sweet spot for the diverse benefits of methylene blue without increasing your serotonin levels. High doses of methylene blue are generally reserved for therapeutic applications, and even then, it must be done under the supervision of a medical practitioner.
If you’re considering adding methylene blue to your health routine, consult with a knowledgeable medical professional first. Together, you’ll be able to work out the dosage specific to your needs, as well as warn you of potential harmful interactions with any medications you’re currently taking.
My Personal Way of Taking Methylene Blue
When it comes to buying methylene blue, you’ll find three types for sale — industrial-grade, chemical-grade (laboratory-grade) and pharmaceutical-grade.
- Buy pharmaceutical-grade methylene blue — Out of the three, the only one you should ever use is the pharmaceutical-grade variety, ideally in solid, capsule or tablet forms. Avoid liquid solutions of methylene blue as dissolving it in water significantly decreases its effectiveness after 48 to 72 hours.
- Don’t use methylene blue for aquariums — You’ve probably seen methylene blue used in maintaining aquariums. That’s because it contains antifungal, antiparasitic and oxygen-transporting properties. While those benefits also sound enticing for therapeutic usage, this type of methylene blue often contains additional harmful contaminants, even posing serious health risks to your aquatic pets.
Never use methylene blue designed for aquariums or other animal-related applications. To protect your health, always choose pharmaceutical-grade, as it undergoes rigorous testing to confirm it is free from impurities.
- Methylene blue will help with reductive stress — Remember not to over-rely on methylene blue to achieve optimal health. In my own case, I have eliminated my regular intake of methylene blue. I find that my daily walks by the ocean are incredibly helpful in managing reductive stress naturally.
However, during times when I’m unable to take a walk by the beach, I would consider taking 5 mg of methylene blue daily, adjusting to 3 mg if I were 75 pounds lighter in weight, and doing so six days a week.
If you’re considering taking methylene blue for its anticancer (or other metabolic) benefits, visit your doctor first to check if it’s suitable for your case. The reason for this is because the appropriate way to use methylene blue is through a prescription, and misuse will put your health at risk.
Frequently Asked Questions About the Anticancer Potential of Methylene Blue
Q: How does methylene blue help fight cancer?
A: Methylene blue works in two ways — photodynamic therapy and metabolic disruption. In photodynamic therapy, it accumulates in cancer cells and, when exposed to specific wavelengths of light, produces reactive oxygen species that destroy tumors while sparing healthy tissue. It also disrupts the altered metabolism of cancer cells, forcing them to rely on normal oxygen-based energy production, weakening and slowing their growth.
Q: What types of cancer have methylene blue been shown to affect?
A: Studies have demonstrated that methylene blue significantly shrinks tumors in colorectal cancer, melanoma and carcinoma. Research also shows that it slows the growth of chemotherapy-resistant ovarian cancer, making it a promising option for hard-to-treat cases.
Q: Is methylene blue safe to use as a cancer treatment?
A: Unlike traditional chemotherapy and radiation, methylene blue does not damage healthy cells. Animal studies have shown minimal toxicity, no severe side effects and a strong safety profile. However, pharmaceutical-grade methylene blue should always be used, and improper dosages or interactions with certain medications, like SSRIs, should be avoided.
Q: How is methylene blue taken for cancer therapy?
A: The most effective and safest method is pharmaceutical-grade methylene blue in capsule or tablet form, with a standard dosage of 5 mg once daily for mitochondrial support.
Q: Can methylene blue be combined with other cancer treatments?
A: Yes, research shows that methylene blue enhances the effects of chemotherapy drugs like carboplatin. It also strengthens the immune system’s response to tumors, which will help improve long-term outcomes. More studies are needed to determine the best combinations and dosing strategies for different cancer types.
- 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 Frontiers in Pharmacology, 14:1264961
- 11, 12, 13, 14, 15, 16 Cancers, 2024, 16(2), 355
Bypass Big Tech Censors
Two Storms, One Harvest
Every food crisis in living memory has been a one-shock event. The 2008 price spike was a commodity bubble. The 2020 shortages were a logistics failure. The 2022 grain scare was a war on one exporter’s ports. Each time, the system bent, adjusted, and recovered, and each time the experts assured us afterward that global markets are simply too big and too diversified to fail.
What nobody in Washington seems eager to discuss is that 2026 is shaping up to be something the modern food system has never actually faced. Two independent shocks, one climatic and one geopolitical, are converging on the same harvest cycle at the same time. Not sequentially. Simultaneously.
Start with the weather. The Pacific Ocean is currently building toward what forecasters now openly call a record event. NOAA’s Climate Prediction Center puts the odds of at least a strong El Niño near 88 percent, with roughly two in three odds it reaches “very strong” status, the tier reserved for perhaps three or four events in the entire satellite era. Every major global model now projects a median peak in Super El Niño territory, and most of them project it exceeding the 2015-16 event, which until now held the modern record. Sea surface anomalies were already brushing the super threshold in mid-July, months before these events normally peak. The atmosphere has already shifted into El Niño mode, and the event is forecast to crest in late fall and early winter.
This is not about “climate change.” It’s about the standard cycles of weather, and the cycle we’re currently in is one that has likely devastated societies in the past. We’re better prepared as a society today, but not all Americans are equally prepared.
Serious households have started doing the quiet math on their own. Grocery bills tell part of the story, and the forecast maps tell the rest, which is why long-term food storage has moved from fringe hobby to mainstream line item in the family budget, with established suppliers like Heaven’s Harvest seeing demand from people who five years ago would have rolled their eyes at the idea. That instinct is not paranoia. It is pattern recognition, and the pattern is worth walking through carefully.
Editor’s Note: Heaven’s Harvest IS a sponsor, but the warnings of this article are real and would be written even if we didn’t have a survival food sponsor. With that said, those who take advantage of what they offer can use promo code “Patriot” for 15% off.
The Fertilizer Clock Is Already Running
While the Pacific warms, the second shock has been unfolding in the Strait of Hormuz. The conflict with Iran turned the world’s most important energy chokepoint into a contested waterway, and the consequences reach far beyond the gas pump. Roughly a third of global fertilizer trade moves through Hormuz, and the disruption sent urea prices up 86 percent year over year by March, with a 53 percent jump in a single month.
The World Bank projects energy prices rising about 24 percent in 2026 and fertilizer about 31 percent. By its own accounting, fertilizer prices ran 35 percent higher in the first five months of this year than the same period last year.
Here is the mechanism the nightly news will not explain. Fertilizer is not a grocery item. It is a time-delayed input. The nitrogen a farmer in Iowa or Punjab could not afford to apply this spring does not show up as a problem this spring. It shows up as a thinner harvest six to twelve months later.
The World Bank’s own food security brief concedes that the effects of reduced applications earlier this season “are likely to become visible only later in harvest outcomes.” Translate that from institutional language into plain English and it means this. The damage is already done, it is already in the ground, and we are simply waiting for it to arrive on the shelf.
Now check the calendar. Six to twelve months from the spring planting season lands us squarely in late 2026 and early 2027. Which is precisely when the strongest El Niño in the instrumental record is forecast to peak, bringing its signature droughts to Southeast Asia, Australia, southern Africa, northern Brazil, and South Asia, the very regions that grow the world’s rice, sugar, and oilseeds.
The World Bank warns openly that a strong El Niño “could disrupt multiple crop belts simultaneously” on top of the conflict-driven input costs. Their baseline projection assumes the Middle East disruptions ease by autumn. What in the last two years of Middle East history suggests that assumption is safe?
The System Has No Slack Left
The comfortable answer is that global markets always adjust. But adjustment requires slack, and the slack is gone. Global cereal production is expected to decline from last year’s records even before El Niño does its work. The UN World Food Programme, hardly a den of right-wing preppers, is calling this the most significant disruption to its supply chains since Covid and the invasion of Ukraine, and its supply chain director put the stakes bluntly.
Today’s supply chain challenges are tomorrow’s hunger crisis.
There is also a political dimension that markets cannot price. When food gets scarce, governments do not behave like economists. They behave like politicians. Export bans, hoarding mandates, and panic buying at the national level turned the modest rice shortfall of 2008 into a global crisis, and analysts are already warning that import-dependent nations are the first dominoes.
The 2015-16 Super El Niño, a far weaker event than what is now forecast, threw tens of millions into food stress across Africa and Asia. This one is projected to be stronger, and it arrives with fertilizer already rationed by price and shipping lanes already contested by missiles.
What Joseph Knew
Scripture does not treat preparation for lean years as faithlessness. It treats it as wisdom delivered in advance to those willing to act on it.
Behold, there come seven years of great plenty throughout all the land of Egypt: And there shall arise after them seven years of famine; and all the plenty shall be forgotten in the land of Egypt.
Joseph did not respond to that warning with a hashtag or a committee. He stored grain during the years of abundance, and when the famine came, Egypt stood while its neighbors begged. The lesson is not that famine is certain. It is that the time to prepare is precisely when preparation still looks optional.
Nobody who filled a pantry in a year of plenty has ever regretted it, and nobody standing in an empty aisle has ever been glad he waited for certainty.
None of this calls for panic, and panic is the enemy of sound judgment anyway. It calls for the same unglamorous prudence our grandparents considered ordinary. Keep some cash margin, know your local growers, and put real food in deep storage while it is cheap and available, because the entire arc of this story is that cheap and available is a closing window.
Families looking for a straightforward place to start can visit Heaven’s Harvest and use promo code Patriot for 15 percent off long-term storable food. The forecasts may yet soften, the strait may yet reopen, and we should pray they do. But hope is a fine thing to hold and a foolish thing to eat.
